A detailed history of Wells Fargo & Company transactions in Pro Phase Labs, Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 1,530 shares of PRPH stock, worth $963. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,530
Previous 1,530 -0.0%
Holding current value
$963
Previous $6,000 50.0%
% of portfolio
0.0%
Previous 0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$4.18 - $7.35 $447 - $786
-107 Reduced 6.54%
1,530 $6,000
Q1 2024

May 10, 2024

BUY
$4.47 - $6.47 $4 - $6
1 Added 0.06%
1,637 $10,000
Q4 2023

Feb 09, 2024

BUY
$4.35 - $5.1 $56 - $66
13 Added 0.8%
1,636 $7,000
Q3 2023

Nov 13, 2023

SELL
$4.23 - $7.53 $29 - $52
-7 Reduced 0.43%
1,623 $7,000
Q2 2023

Aug 15, 2023

BUY
$7.15 - $9.78 $64 - $88
9 Added 0.56%
1,630 $11,000
Q1 2023

May 12, 2023

BUY
$6.62 - $9.57 $6 - $9
1 Added 0.06%
1,621 $12,000
Q4 2022

Feb 13, 2023

BUY
$8.78 - $12.47 $35 - $49
4 Added 0.25%
1,620 $15,000
Q3 2022

Nov 14, 2022

BUY
$8.96 - $14.7 $8 - $14
1 Added 0.06%
1,616 $18,000
Q2 2022

Aug 12, 2022

BUY
$6.52 - $13.24 $45 - $92
7 Added 0.44%
1,615 $20,000
Q4 2021

Feb 14, 2022

BUY
$5.13 - $7.89 $10 - $15
2 Added 0.12%
1,608 $12,000
Q3 2021

Nov 15, 2021

SELL
$4.89 - $7.82 $19 - $31
-4 Reduced 0.25%
1,606 $8,000
Q2 2021

Aug 16, 2021

SELL
$4.61 - $6.83 $4 - $6
-1 Reduced 0.06%
1,610 $9,000
Q1 2021

May 13, 2021

BUY
$6.19 - $16.0 $9,637 - $24,912
1,557 Added 2883.33%
1,611 $12,000
Q3 2020

Nov 05, 2020

SELL
$1.4 - $3.87 $4 - $11
-3 Reduced 5.26%
54 $0
Q2 2020

Aug 13, 2020

BUY
$1.2 - $1.99 $1 - $1
1 Added 1.79%
57 $0
Q1 2020

May 14, 2020

BUY
$1.74 - $2.1 $97 - $117
56 New
56 $0

Others Institutions Holding PRPH

About ProPhase Labs, Inc.


  • Ticker PRPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 16,024,400
  • Market Cap $10.1M
  • Description
  • ProPhase Labs, Inc. engages in the research, development, manufacture, distribution, marketing, and sale of over the counter (OTC) consumer healthcare products and dietary supplements in the United States. The company operates in two segments, Diagnostic Services and Consumer Products. It offers a range of OTC dietary supplements, including Lege...
More about PRPH
Track This Portfolio

Track Wells Fargo & Company Portfolio

Follow Wells Fargo & Company and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.